Atopic dermatitis (AD) is typically a big issue during early childhood. But it also afflicts up to 5% of adults. Mild cases, which are virtually always managed in primary care, are usually ...

ORLANDO, Fla. — The interleukin (IL)-4 and IL-13 inhibitor dupilumab improved itch symptoms and curtailed disease activity while also reducing oral corticosteroid use in older patients with bullous ...

Please provide your email address to receive an email when new articles are posted on . In those with and those without a history of CVD/metabolic disease, patients receiving dupilumab vs. placebo had ...